Victory Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$603K Buy
21,129
+6,099
+41% +$162K 0.06% 220
2026
Q2
$362K Sell
15,030
-1,058
-7% -$27.7K 0.04% 255
2026
Q1
$452K Buy
16,088
+1,964
+14% +$52.3K 0.06% 201
2025
Q4
$352K Buy
14,124
+3,084
+28% +$77.8K 0.04% 219
2025
Q3
$284K Buy
11,040
+2,727
+33% +$67.3K 0.04% 197
2025
Q2
$202K Buy
+8,313
New +$194K 0.03% 222

Other funds holding PFE

Victory Financial Group's PFE Position: Q3 2026 in Review

Victory Financial Group increased its Pfizer (PFE) stake by 41% in Q3 2026, buying an estimated $162K and bringing the position to 21,129 shares worth $603K. The position accounts for 0.06% of the portfolio, ranked #220.

Victory Financial Group first reported a position in PFE in Q2 2025 and has held it in 6 quarters since. 2,890 funds tracked by Wall St. Rank hold PFE as of Q3 2026.

  • Victory Financial Group held 21,129 shares of Pfizer worth $603K as of Q3 2026.
  • Victory Financial Group bought 6,099 Pfizer shares in Q3 2026, an estimated $162K.
  • Pfizer made up 0.06% of Victory Financial Group's portfolio in Q3 2026, its #220 holding.
  • Victory Financial Group first reported a position in Pfizer in Q2 2025 and has held it in 6 quarters since.
  • 2,890 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.

Based on Victory Financial Group's 13F filing for Q3 2026, filed 27 Oct 2026.